Achieve Life Sciences Inc (SP4P) — Strategic Asset Allocation Index
Achieve Life Sciences Inc (SP4P) has a Strategic Asset Allocation Index of 1.5% as of December 2022. Strategic assets (PP&E of €127.00K plus long-term investments of €-) total €127.00K, measured against net assets of €8.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Achieve Life Sciences Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Achieve Life Sciences Inc Strategic Asset Allocation Index (2017–2022)
This chart shows how Achieve Life Sciences Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of December 2022, the index stands at 1.5%, representing strategic assets of €127.00K against net assets of €8.30 Million EUR. For live market cap and overall valuation, see SP4P market cap.
Annual Strategic Asset Allocation Index for Achieve Life Sciences Inc (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Achieve Life Sciences Inc from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Achieve Life Sciences Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.5% | €127.00K | €127.00K | €- | €8.30 Million | ▲ +1.3 pp |
| 2021 | 0.2% | €64.00K | €64.00K | €- | €28.04 Million | ▼ -0.2 pp |
| 2020 | 0.4% | €146.00K | €146.00K | €- | €37.29 Million | ▼ -1.7 pp |
| 2019 | 2.1% | €386.00K | €386.00K | €- | €18.05 Million | ▲ +1.9 pp |
| 2018 | 0.2% | €35.00K | €35.00K | €- | €15.80 Million | ▼ -0.5 pp |
| 2017 | 0.7% | €59.00K | €59.00K | €- | €7.88 Million | — |